This may be especially important given recent findings observing that dexmedetomidine induced IL-6 secretion from stromal stellate cells and pro-tumorigenic signaling in hepatocellular cancer cells [31], although whether this is relevant to that distinct TME is to be determined. This evidence concerns the gene IL6 and hepatocellular carcinoma.